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www.jacctctabstracts2013.com TUESDAY, OCTOBER 29, 2013, 3:30 PM–5:30 PMimplantation, balanced with a sustained antiproliferative effect up to 12 months of
follow-up. A larger study is warranted to examine the safety of shortening the dual
antiplatelet therapy regimen on this background.
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Cambridge, United Kingdom, 3University of Cambridge, Cambridge, United
Kingdom, 4Addenbrooke's Hospital, Cambridge, United Kingdom
Background: Angiographically-identiﬁed geographical miss (GM) of atherosclerotic
plaques during percutaneous coronary intervention (PCI) is common. However, the
relationship between GM and the underlying plaque as identiﬁed by virtual histology
intravascular ultrasound (VH-IVUS) as not been studied. We aimed to determine
whether GM is associated with speciﬁc plaque characteristics, PCI-related myocardial
infarction (MI4a) and future major adverse cardiovascular events (MACE).
Methods: Patients with stable angina (n¼100) or myocardial infarction (MI) (n¼70)
underwent 3-vessel VH-IVUS prior to PCI. GM was deﬁned as 3 uncovered VH-
IVUS frames in stented lesions with plaque area >40% at either stent edge. MACE
comprised death, MI, hospitalization with unstable angina or unplanned
revascularization.
Results: 30372mm VH-IVUS and 1096 lesions were analysed: 858 (78.2%) plaques
were unstented, 165 (15.1%) stented without GM, and 80 (7.3%) stented with GM.
GM was associated with increased plaque volume, necrotic core %, dense calcium %
and VH-deﬁned thin cap ﬁbroatheroma (VHTCFA) and with reduced ﬁbrous tissue %
(table). GM was not associated with increased MI4a (33 (54%) vs. 71 (72%), p¼0.15)
or inﬂammatory cytokine release. MACE (n¼43) occurred in 28 patients over
a median follow-up of 1115 [968-1537] days. MACE were directly linked to 11/858
(0.8%) unstented plaques, 7/165 (4.2%) fully covered stented lesions and 8/80 (10%)
stented lesions with GM (log rank p<0.001). In patients presenting with MI, stented
lesions with GM had increased future MACE compared to fully covered lesions (log
rank p¼0.015).Plaque parameters
Completely
covered plaques Geographical miss p value
(n=165) (n=80)
Plaque Burden
70% (n (%))
110 (67%) 62 (78%) 0.058
Minimum luminal
area 4mm2
(n (%))
126 (76%) 54 (68%) 0.18
Remodeling index 1.03 [0.91-1.14] 1.00 [0.91-1.19 0.9
Segment length
(mm)
17 [8-29] 32 [19-51] <0.001
Plaque volume
(mm3)
122 [53-216] 271 [131-443] <0.001
Fibrous tissue (%) 59 [51-66] 55 [48-61] 0.001
Necrotic core (%) 20 [15-26] 25 [18-29] 0.001
Dense calcium (%) 7 [3-12] 10 [6-16] <0.001
VH-IVUS
pathological
intimal thickening
(n (%))
17 (10%) 1 (1%) 0.011
VH-IVUS
ﬁbrocalciﬁc plaque
(n (%))
8 (5%) 5 (6%) 0.65
VH-IVUS thick-
capped
ﬁbroatheroma
(n (%))
17 (10%) 7 (9%) 0.4
VH-IVUS thin-
capped
ﬁbroatheroma
(VHTCFA) (n (%))
111 (67%) 66 (83%) 0.013
Non-calciﬁed
VHTCFA (n (%))
35 (21%) 10 (13%) 0.095
Calciﬁed VHTCFA
(n (%))
80 (48%) 55 (69%) 0.003
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sition and type and with future MACE in MI patients undergoing PCI. Whether the
association of GM with future MACE is independent of adverse plaque anatomy is not
clear and requires a much larger study to determine.
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Background: Implantation of drug-eluting stents (DES) in patients with ST-segment
elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary
intervention (PCI) reduces in-stent restenosis compared with bare metal stents (BMS),
however, the long-term risk of DES use in STEMI has been pointed. Previous patho-
logical and optical coherence tomography (OCT) study reported that ﬁrst generation
DES use in STEMI resulted in higher rates of uncovered and malapposed stent struts at
follow-up. The long-term safety of second generation everolimus-eluting stents (EES)
use in STEMI remains unknown. We used OCT to examine vascular response including
strut coverage and malapposition in patients with STEMI treated with EES and BMS.
Methods: We enrolled 85 patients with STEMI who underwent primary stenting and
10-month follow-up OCT (EES: 47 patients and BMS 38 patients).
Results: A total of 18244 stent struts were analyzed. There were no signiﬁcant
differences in the percentage of uncovered and malapposed stent struts per lesion
between 2 stents (2.283.08% versus 1.472.46%, P¼0.182 and 0.571.22% versus
0.410.84%,P¼0.499, respectively). Averaged neointimal thickness was smaller in
EES lesions (103  38 mm vs. 385  151 mm, P<0.001). Intra-stent thrombus was
observed in 12.8% of EES lesions and 10.5% of BMS lesions (p ¼ 0.750).
Conclusions: In STEMI patients undergoing primary PCI, there are no signiﬁcant
differences in the percentage of uncovered and malapposed stent struts, and the
incidence of intra-stent thrombus at 10-month follow-up between EES and BMS. On
the other hands, EES as compared with BMS signiﬁcantly reduces neointimal
hyperplasia. EES has a potential to achieve low late loss without sacriﬁcing safety.
TCT-568
Patients Who Have Ruptured Plaque at Culprit Lesion Are At High Risk of
Distal Embolization Even If They Do Not Have Acute Coronary Syndrome
Koshi Matsuo1, Yasunori Ueda1
1Osaka Police Hospital, Osaka, Japan
Background: Slow ﬂow or no re-ﬂow phenomenon during coronary intervention is
mainly caused by distal embolization of thrombus and plaque debris, and is associated
with unfavorable long-term clinical outcomes. This phenomenon often occurs in the
patients with acute coronary syndrome (ACS) but also in some patients with stable
angina. However, the high-risk patients of distal embolization are not well understood.
Methods: Consecutive patients with acute myocardial infarction (AMI) (n¼192),
those with unstable angina (UA) (n¼89), and those with stable coronary heart disease
(CHD) (n¼211) who received coronary intervention with ﬁlter-type distal protection
device (Filtrap) were prospectively enrolled. We compared between the groups the
frequency of ﬁlter slow ﬂow/ no-reﬂow phenomenon and of distal embolization
captured by the ﬁlter device. We examined by angioscopy if ruptured plaque was
present at the target lesion and analyzed its association with ﬁlter slow ﬂow/ no
re-ﬂow phenomenon or distal embolization.
Results: Filter slow ﬂow/ no re-ﬂow phenomenon occurred most frequently in AMI
patients, although there was no difference between UA and CHD patients (43% vs.
20% vs. 18%, P<0.001). Filter slow ﬂow/ no re-ﬂow phenomenon occurred more
frequently in the patients with vs. without ruptured plaque in each patient group (AMI
patients: 79% vs. 8%, P<0.001; UA patients: 57% vs. 7%, P¼0.001; CHD patients:
72% vs. 6%, P<0.001). Among the patients without ruptured plaque, the incidence
was not different between the patient groups.
Conclusions: Although AMI patients are at high risk of ﬁlter slow ﬂow/ no re-ﬂow
phenomenon and of distal embolization than UA or CHD patients, the risk was
associated with the presence of ruptured plaque. Patients with ruptured plaque had the
higher risk than those without it regardless of the diagnosis.
TCT-569
Pre-interventional Plaque Composition Assessed by Virtual Histology
Intravascular Ultrasound Predicts Plaque Shift after Stent Implantation
Kyuhachi Otagiri1, Kenji Sakamoto1, Ryotaro Yamada1, Hideki Kitahara1,
Shigemitsu Tanaka1, Joo-Yong Hahn1, Paul Yock1, Peter J. Fitzgerald1,
Yasuhiro Honda1
1Stanford University, Stanford, CA
Background: Signiﬁcant plaque shift during stenting can result in side branch
compromise in certain cases. This study aimed to evaluate potential effects ofacts/POSTER/Intravascular Imaging and PCI B171
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(VH-IVUS) on plaque shift during stenting.
Methods: Serial IVUS was performed pre- and post-procedure in 45 patients treated
with stents. Volume index (VI: volume/length, mm3/mm) was measured for lumen,
vessel and plaque within the target (stent) segment and at 5-mm proximal and distal
adjacent segments. By VH-IVUS, each plaque component, classiﬁed as ﬁbrous, ﬁbro-
fatty, necrotic core or dense calcium, was quantiﬁed. At reference segments, signiﬁ-
cant plaque shift was deﬁned as a 1.0 mm3/mm increase in plaque VI from pre- to
post-procedure.
Results: By gray-scale IVUS at pre-procedure, the signiﬁcant plaque-shift group
showed trends toward larger plaque burden with a greater degree of step-up/down in
lumen VI from the target to reference segments (table). Pre-procedural VH-IVUS
showed larger ﬁbrous and ﬁbro-fatty components at the target segment in the shift
group than in the non-shift group with a similar tendency at the reference segments
(table). In serial analysis, the signiﬁcant plaque shift resulted predominately from
a signiﬁcant decrease in the ﬁbrous component at the target segment (3.551.75 to
1.821.15 mm3/mm, p<0.01) with a corresponding increase in the same component
at the reference segments (2.391.03 to 3.231.11 mm3/mm, p<0.01).　
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Conventional IVUS parameters at pre-procedure
Plaque VI 9.223.20 7.492.55 0.07 8.041.84 6.133.22 0.05
Vessel VI 15.124.48 12.533.86 0.07 18.114.03 13.235.69 <0.01
Lumen VI 5.901.88 5.041.65 0.15 10.072.91 7.113.14 <0.01
Plaque components at pre-procedure
Fibrous VI 3.551.75 2.601.11 0.04 2.391.03 1.651.22 0.05
Fibro-fatty VI 1.100.96 0.590.52 0.03 0.550.50 0.330.38 0.09
Necrotic core
VI
1.030.45 0.930.64 0.64 0.680.65 0.560.57 0.51
Dense
calcium VI
0.290.20 0.330.52 0.76 0.220.25 0.210.30 0.98
VI: volume index (mm3/mm)Conclusions: Pre-interventional plaque characterization predicted signiﬁcant plaque
shift during stenting better than conventional IVUS parameters. Compared with
compliant plaque components that may be well compressed during stenting, a large
amount of ﬁbrous tissue at the target segment may lead to longitudinal plaque
redistribution to the adjacent segments.
TCT-570
Intravascular Ultrasound Predictor of Late Lumen Gain of the Distal Reference
Segments after Successful Percutaneous Coronary Intervention
Yoji Neishi1, Hiroyuki Okura1, Kenzo Fukuhara1, Terumasa Koyama1,
Ryotaro Yamada1, Teruyoshi Kume1, Akihiro Hayashida1, Takahiro Kawamoto1,
Kiyoshi Yoshida1
1Kawasaki medical school, Kurashiki , Japan
Background: A recent study reported that lumen area at the distal reference segments
increases in 69 % of the patients with successful total occlusion recanalization at 6-
month follow-up. Pathological studies have shown that vessel shrinkage is accom-
panied with folding of the internal elastic membrane (IEM). Peri-medial high echoic
band (PHB) by intravascular ultrasound (IVUS) was observed during coronary spasm
and PHB may suggest the presence of the folding of IEM. The aim of this study was to
investigate IVUS predictor of chronic enlargement of lumen diameter at the distal
reference segment of the target lesion after percutaneous coronary intervention (PCI).
Methods: Twenty seven patients with angina pectoris who underwent successful PCI
were enrolled. IVUS was performed at the distal segment of the target lesion after
successful PCI. Lumen diameter of the distal segment was measured by quantitative
coronary angiography (QCA) analysis at baseline and at 9 months after PCI. Presence
of late lumen gain (LLG) was deﬁned as (lumen diameter at 9months) minus (lumen
diameter at baseline) divided by (lumen diameter at baseline) of greater than 10B172 JACC Vol 62/18/Suppl B j October 27–Novepercent. Patients were divided into 2 groups according to the presence (LLG group:
n¼16) or absence (non-LLG group: n¼11) of LLG. Quantitative and qualitative IVUS
ﬁndings were compared between LLG group and non-LLG group.
Results: External elastic membrane and plaque plus media cross sectional area were
similar between the 2 groups. Lumen cross sectional area tended to be smaller (4.1
1.8 vs. 6.7 3.4, p¼0.07) and plaque burden tended to be greater (43 15 vs. 33 10,
p¼0.08) in LLG group than in non-LLG group. PHB was more frequently observed in
LLG group than in non-LLG group (88% vs. 16%, p¼0.007). By multivariate anal-
ysis, PHB was the only IVUS predictor of LLG (OR: 15.26, 95% CI: 1.10 to 211,
p¼0.042).
Conclusions: Presence of PHB by IVUS predicts chronic enlargement of the coronary
segments distal to the target lesion.
TCT-571
The Impact of Predilatation on Bioresorbable Vascular Scaffold Expansion In
Vivo – insights from Optical Coherence Tomography
Adam J. Brown1, Liam M. McCormick1, Denise M. Braganza1, Stephen P. Hoole1,
Nick E. West1
1Papworth Hospital, Cambridge, United Kingdom
Background: Suboptimal metallic stent expansion may be associated with increased
instent restenosis, TVR & stent thrombosis. Manufacturers' compliance charts relate
implanted stent diameter to nominal size & deployment pressure, but these are based
on in vitro measurements, & are unreliable in predicting ﬁnal dimensions. Early data
from bioresorbable vascular scaffolds (BVS) suggest low complication rates but
concerns remain regarding mechanical strength/recoil, and there is limited real-world
data on in vivo BVS expansion.
Methods: All patients receiving BVS at a single center from 08/12–06/13 were
included. All lesions were predilated before BVS implant with postdilatation at
operator discretion. OCT was performed after PCI to determine BVS expansion.
Within each 1mm longitudinal interval of BVS segments, measurements were taken
for minimum scaffold diameter (MSD) & cross-sectional area (CSA). BVS expansion
was deﬁned as MSD (or CSA) divided by predicted MSD (PMSD) (or PCSA). Central
segments were deﬁned as the middle 1/3 of the length of each BVS; peripheral
segments those distal or proximal to central segments.
Results: 28 BVS (15/28 3.0 x 18mm) were implanted in 26 patients; most (25/28)
were deployed at maximum recommended deployment pressure (16atm). 16 patients
(62%) underwent postdilatation. In total, 480 frames of BVS segment were analysed.
Overall, 99% of MSD (1.86-3.73mm; mean 2.840.34mm) were smaller than pre-
dicted (2.94-4.01mm; mean 3.430.3mm). Only 24% of analyzed frames achieved
90% of PMSD, & 6.9% the PCSA. Overall, BVS achieved 82.88.5% of PMSD and
82.512.0% of PCSA. Expansion was reduced in central vs peripheral segments
(MSD 79.98.1% vs 84.48.3%, p<0.001; CSA 78.711.0% vs 84.612.0%,
p<0.001), even in lesions predilated with 1:1 balloon:scaffold sizing (MSD
83.45.2% vs 88.56.3%, p<0.001; CSA 84.27.4% vs 88.68.7%, p¼0.01).
Conclusions: BVS compliance charts are unreliable in predicting ﬁnal in vivo
dimensions, which may be dependent on lesion/vessel compliance. BVS expansion is
reduced in the region of treated target lesions; as aggressive postdilatation is not
recommended, our data highlight the importance of optimal predilatation before BVS
implant.
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Impact of calcium-deposit for left circumﬂex ostium narrowing after crossover
stenting in distal left main bifurcation: An Intravascular Ultrasound Study in the
Milan and Fukuyama Registry.
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Background: A provisional single-stenting is considered a default strategy for non-
true bifurcation lesion in distal unprotected left main coronary artery (ULMCA).
However, in certain cases, left circumﬂex artery (LCx)-ostium stenting may be
necessary. The aim of this study was to evaluate predictors of residual LCx stenosis
post ULMCA stenting according to baseline intravascular ultrasound (IVUS).
Methods: A total of 43 patients underwent percutaneous coronary intervention with
drug-eluting stents for non-true bifurcation lesions in ULMCA. Pre-procedural IVUS
was performed to measure cross-sectional areas at following segments: LMCA, left
anterior descending artery (LAD)-ostium and LCx-ostium. Post-stenting-narrowing
(PSN) at LCx-ostium was deﬁned as more than 75% angiographic stenosis.
Results: PSN occurred in 19 (44.2%) patients. IVUS data are shown in Table.
Calciﬁed plaque at the opposite site of LCx-oriﬁce was more frequently observed in
PSN group as compared to non-PSN group (78.9% vs.16.7%, p <0.01). In multi-
variate analysis, the arc of calcium was an independent predictor of PSN.mber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
